SCHEMBL652147

SCHEMBL652147

C[Si](C)(C)C#Cc1c2cc3ccccc3cc2c(C#C[Si](C)(C)C)c2cc3ccccc3cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.41
NQO1 P15559 1/20 0.38
MAPT P10636 3/20 0.35
CYP1A2 P05177 6/20 0.33
ALDH1A1 P00352 3/20 0.33
CYP2A6 P11509 3/20 0.33
HSD17B10 Q99714 3/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 2/20 0.33
CYP1B1 Q16678 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NQO2 P16083 1/20 0.33
HIF1A Q16665 1/20 0.33
NPC1 O15118 1/20 0.33
USP2 O75604 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
PI4KA P42356 1/20 0.32
PI4K2B Q8TCG2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14514096 0.96 ELANE (0.39) ELANENQO1MAPTCYP1A2ALDH1A1
SCHEMBL656268 0.93 ELANE (0.37) ELANENQO1MAPTCYP1A2ALDH1A1
SCHEMBL12590002 0.91 ELANE (0.39) ELANENQO1MAPTCYP1A2ALDH1A1
SCHEMBL12590003 0.87 CYP1A2 (0.47) ELANENQO1MAPTCYP1A2ALDH1A1
SCHEMBL5014197 0.86 CYP1A2 (0.38) ELANEMAPTCYP1A2ALDH1A1CYP2A6
SCHEMBL12590007 0.84 ELANE (0.32) ELANECYP2A6
SCHEMBL12861304 0.84 ESR1 (0.46) ELANEMAPTKDM4ETDP1ESR1
SCHEMBL15851389 0.83 ESR1 (0.40) CYP1A2ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL1470735 0.82 ALDH1A1 (0.35) ELANEMAPTCYP1A2ALDH1A1HSD17B10
SCHEMBL29690232 0.82 ALDH1A1 (0.35) ELANEMAPTCYP1A2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842942-B2 Organic semiconducting layers MERCK PATENT GMBH (DE) 2010-11-30 US claimed
US-20190348619-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM SOLVAY SA (BE) 2019-11-14 US disclosed
US-20190259964-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM SOLVAY SA (BE) 2019-08-22 US disclosed
US-20190252624-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM SOLVAY SA (BE) 2019-08-15 US disclosed
WO-2017216168-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM SOLVAY SA (BE) 2017-12-21 WO disclosed
EP-3258511-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM Solvay SA (BE) 2017-12-20 EP disclosed
EP-3257849-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM Solvay SA (BE) 2017-12-20 EP disclosed
EP-3258509-A1 9,9-DISUBSTITUTED 9,10-DIHYDROACRIDINE COMPOUNDS AND THEIR USE FOR DOPING CRYSTALLINE ORGANIC SEMICONDUCTORS Solvay SA (BE) 2017-12-20 EP disclosed
US-20170346028-A1 ORGANIC SEMICONDUCTOR COMPOSITION SOLVAY SA (BE) 2017-11-30 US disclosed
US-20170346028-A1 ORGANIC SEMICONDUCTOR COMPOSITION SOLVAY SA (BE) 2017-11-30 US disclosed
WO-2007081991-A9 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS UNIV PENNSYLVANIA (US) 2007-09-07 WO disclosed
EP-1808866-A1 Organic semiconducting layer formulations comprising polyacenes and organic binder polymers Merck Patent GmbH (DE) 2007-07-18 EP disclosed
US-20070137520-A1 ORGANIC SEMICONDUCTING LAYERS FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-06-21 US disclosed
US-20070137520-A1 ORGANIC SEMICONDUCTING LAYERS FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-06-21 US disclosed
US-20070102696-A1 Organic semiconducting layers FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-05-10 US disclosed
US-20070102696-A1 Organic semiconducting layers FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-05-10 US disclosed
EP-1783781-A2 ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS Merck Patent GmbH (DE) 2007-05-09 EP disclosed
EP-1687830-A2 ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS Merck Patent GmbH (DE) 2006-08-09 EP disclosed
WO-2005055248-A2 ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS MERCK PATENT GMBH (DE) 2005-06-16 WO disclosed
US-6690029-B1 Substituted pentacenes and electronic devices made with substituted pentacenes UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2004-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190348619-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM AR, AHR, AXIN2 ELANE 4437/4885NQO1 2725/4885MAPT 1722/4885
US-20070102696-A1 Organic semiconducting layers SSB, RCOR3, CNKSR1 ELANE 1532/4885NQO1 2167/4885MAPT 4332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.